라이브 바이오테라퓨틱스 제품 및 미생물 CDMO 시장 : 서비스 유형별, 오퍼레이션 규모별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Live Biotherapeutics Products & Microbe CDMO Market size was valued at USD 20.34 million in 2023, expanding at a CAGR of 40.5% from 2024 to 2032.

The Live Biotherapeutics Products & Microbe CDMO market involves developing, manufacturing, and commercializing therapeutic products based on live microbes for medical applications. The increasing demand for microbiome-based therapies is driven by awareness of the microbiome's role in health, advancements in microbial engineering enabling customized therapeutics, and the rising prevalence of chronic diseases facilitating market entry. However, challenges such as the complexity of microbiome research, manufacturing scalability issues, safety concerns, and limited market understanding pose restraints on market growth. Opportunities lie in expanding therapeutic applications beyond gastrointestinal disorders, increased R&D investment in microbiome therapeutics, and personalized medicine approaches enhancing targeted treatment strategies in healthcare.

Live Biotherapeutics Products & Microbe CDMO Market- Market Dynamics

Advancing R&D Initiatives in Next-Generation Live Biotherapeutics and Microbiome Contract Manufacturing

Advancing R&D initiatives in next-generation live biotherapeutics and microbiome contract manufacturing are reshaping therapeutic development. For instance, the National Institutes of Health (NIH) has allocated significant funding towards microbiome research, highlighting its importance in healthcare innovation. Additionally, leading biopharmaceutical companies like Seres Therapeutics and Vedanta Biosciences are pioneering novel live biotherapeutic candidates, emphasizing the potential of microbiome-based therapies. Collaborations between academic institutions and CDMOs, such as the partnership between the University of California, San Diego, and SGI-DNA for synthetic biology solutions, showcase the growing integration of advanced technologies in microbiome-focused manufacturing. These efforts underscore a transformative shift towards personalized, microbiome-targeted therapeutics with broad clinical implications.

Live Biotherapeutics Products & Microbe CDMO Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 40.5% over the forecast period (2024-2032)

Based on Service Type segmentation, Manufacturing Services was predicted to show maximum market share in the year 2023

Based on the Scale of Operation segmentation, Clinical Scale Operations was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Live Biotherapeutics Products & Microbe CDMO Market- Segmentation Analysis:

The Global Live Biotherapeutics Products & Microbe CDMO Market is segmented based on Service Type, Scale of Operation, Application, and Region.

The market is divided into two categories based on Service Type: Development Services and Manufacturing Services. Consumers typically prioritize Manufacturing Services over Development Services due to the critical need for specialized manufacturing capabilities in producing live biotherapeutic products. Efficient and scalable manufacturing processes are essential for the commercialization and market supply of microbiome-based therapies.

The market is divided into three categories based on Scale of Operation: Preclinical Scale Operations, Clinical Scale Operations, and Commercial Scale Operations. Operations typically prioritize Clinical Scale Operations followed by Commercial Scale Operations and then Preclinical Scale Operations. Clinical scale operations are critical for advancing product development towards regulatory approval and commercialization, while commercial scale operations ensure market supply and scalability of live biotherapeutics.

Live Biotherapeutics Products & Microbe CDMO Market- Geographical Insights

North America holds a prominent position, driven by robust R&D activities and investments in microbiome-based therapies by leading pharmaceutical and biotechnology companies. Europe follows closely, with established regulatory frameworks supporting innovation in live biotherapeutics and CDMO services. Asia Pacific showcases rapid growth potential, attributed to increasing healthcare expenditure, rising adoption of advanced biotechnology, and growing partnerships between local and international players. Emerging economies in this region, particularly in countries like China and India, are witnessing a surge in microbiome-focused research and development, contributing to market expansion.

Live Biotherapeutics Products & Microbe CDMO Market- Competitive Landscape:

Key players like Lonza Group, Charles River Laboratories, and Catalent are at the forefront, offering comprehensive CDMO services for live biotherapeutics development and manufacturing. Seres Therapeutics and Vedanta Biosciences lead in live biotherapeutics products, focusing on microbiome-based therapies for various indications. Collaborations such as Bacteria and Seres Therapeutics for commercial manufacturing highlight the trend towards partnerships to enhance manufacturing capabilities and expand market reach. Emerging companies like SBT Instruments contribute innovative technologies, while established players invest in R&D to redefine the future of microbiome-focused therapies and contract manufacturing services. This competitive landscape underscores ongoing efforts to drive innovation and meet the growing demand for advanced live biotherapeutic products and CDMO solutions. Several companies are collaborating for the development and production of innovative live biotherapeutics. For instance, in October 2019, 4D Pharma plc announced a research collaboration and licensing agreement with MSD, Merck & Co., Inc., to discover and develop Live Biotherapeutic Products (LBPs) for vaccines.

Recent Developments:

In June 2023, Biose Industrie and SBT Instruments collaborated to integrate rapid viable cell counts into Biose's manufacturing, setting a new standard for microbe enumeration. This integration aims to expedite clinical trials and market approval for Biose's live biotherapeutic products.

In November 2021, Bacthera and Seres Therapeutics are collaborating to manufacture SER-109, Seres' lead product candidate for recurrent Clostridioides difficile infection (CDI). Bacthera is establishing a dedicated commercial manufacturing facility within its new Microbiome Center of Excellence located on Lonza's Ibex campus in Visp, Switzerland.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

4D Pharma PLC

Catalent, Inc.

Chr. Hansen Holding A/S

Evelo Biosciences, Inc.

Evonik Industries AG

Ferring Pharmaceuticals

Lonza Group AG

Microbiotica Ltd.

Pivot Bio

Rebiotix, Inc. (a Ferring Pharmaceuticals company)

Samsung Biologics

Second Genome, Inc.

Seres Therapeutics, Inc.

Synlogic, Inc.

Vedanta Biosciences, Inc.

Wacker Chemie AG

Others

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

• Development Services
• Manufacturing Services
• Others

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY SCALE OF OPERATION- MARKET ANALYSIS, 2019 - 2032

• Preclinical Scale Operations
• Clinical Scale Operations
• Commercial Scale Operations

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• C.difficle
• Crohn's disease
• IBS
• Diabetes
• Others

GLOBAL LIVE BIOTHERAPEUTICS PRODUCTS & MICROBE CDMO MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1.Live Biotherapeutics Products & Microbe CDMO Market Overview

• 1.1.Study Scope
• 1.2.Market Estimation Years

2.Executive Summary

• 2.1.Market Snippet
  • 2.1.1.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Service Type
  • 2.1.2.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Scale of Operation
  • 2.1.3.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Application
  • 2.1.4.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Country
  • 2.1.5.Live Biotherapeutics Products & Microbe CDMO Market Snippet by Region
• 2.2.Competitive Insights

3.Live Biotherapeutics Products & Microbe CDMO Key Market Trends

• 3.1.Live Biotherapeutics Products & Microbe CDMO Market Drivers
  • 3.1.1.Impact Analysis of Market Drivers
• 3.2.Live Biotherapeutics Products & Microbe CDMO Market Restraints
  • 3.2.1.Impact Analysis of Market Restraints
• 3.3.Live Biotherapeutics Products & Microbe CDMO Market Opportunities
• 3.4.Live Biotherapeutics Products & Microbe CDMO Market Future Trends

4.Live Biotherapeutics Products & Microbe CDMO Industry Study

• 4.1.PEST Analysis
• 4.2.Porter's Five Forces Analysis
• 4.3.Growth Prospect Mapping
• 4.4.Regulatory Framework Analysis

5.Live Biotherapeutics Products & Microbe CDMO Market: COVID-19 Impact Analysis

• 5.1.Pre-COVID-19 Impact Analysis
• 5.2.Post-COVID-19 Impact Analysis
  • 5.2.1.Top Performing Segments
  • 5.2.2.Marginal Growth Segments
  • 5.2.3.Top Looser Segments
  • 5.2.4.Marginal Loss Segments

6.Live Biotherapeutics Products & Microbe CDMO Market Landscape

• 6.1.Live Biotherapeutics Products & Microbe CDMO Market Share Analysis, 2023
• 6.2.Breakdown Data, by Key Manufacturer
  • 6.2.1.Established Players' Analysis
  • 6.2.2.Emerging Players' Analysis

7.Live Biotherapeutics Products & Microbe CDMO Market - By Service Type

• 7.1.Overview
  • 7.1.1.Segment Share Analysis, By Service Type, 2023 & 2032 (%)
  • 7.1.2.Development Services
  • 7.1.3.Manufacturing Services
  • 7.1.4.Others

8.Live Biotherapeutics Products & Microbe CDMO Market - By Scale of Operation

• 8.1.Overview
  • 8.1.1.Segment Share Analysis, By Scale of Operation, 2023 & 2032 (%)
  • 8.1.2.Preclinical Scale Operations
  • 8.1.3.Clinical Scale Operations
  • 8.1.4.Commercial Scale Operations

9.Live Biotherapeutics Products & Microbe CDMO Market - By Application

• 9.1.Overview
  • 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 9.1.2.C.difficle
  • 9.1.3.Crohns disease
  • 9.1.4.IBS
  • 9.1.5.Diabetes
  • 9.1.6.Others

10.Live Biotherapeutics Products & Microbe CDMO Market- By Geography

• 10.1.Introduction
  • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2.North America
  • 10.2.1.Overview
  • 10.2.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in North America
  • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4.North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  • 10.2.5.North America Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  • 10.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.7.U.S.
    • 10.2.7.1.Overview
    • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3.U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.2.7.4.U.S. Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.2.7.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.8.Canada
    • 10.2.8.1.Overview
    • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3.Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.2.8.4.Canada Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.2.8.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 10.3.Europe
  • 10.3.1.Overview
  • 10.3.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Europe
  • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4.Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  • 10.3.5.Europe Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  • 10.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.7.Germany
    • 10.3.7.1.Overview
    • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3.Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.3.7.4.Germany Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.3.7.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.8.Italy
    • 10.3.8.1.Overview
    • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3.Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.3.8.4.Italy Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.3.8.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.9.United Kingdom
    • 10.3.9.1.Overview
    • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3.United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.3.9.4.United Kingdom Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.3.9.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.10.France
    • 10.3.10.1.Overview
    • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3.France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.3.10.4.France Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.3.10.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.11.Russia
    • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2.Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.3.11.3.Russia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.3.11.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.12.Netherlands
    • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2.Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.3.12.3.Netherlands Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.3.12.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.13.Sweden
    • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2.Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.3.13.3.Sweden Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.3.13.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.14.Poland
    • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2.Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.3.14.3.Poland Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.3.14.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.15.Rest of Europe
    • 10.3.15.1.Overview
    • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 10.4.Asia Pacific (APAC)
  • 10.4.1.Overview
  • 10.4.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Asia Pacific
  • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4.Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  • 10.4.5.Asia Pacific Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  • 10.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.7.India
    • 10.4.7.1.Overview
    • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3.India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.4.7.4.India Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.4.7.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.8.China
    • 10.4.8.1.Overview
    • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3.China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.4.8.4.China Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.4.8.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.9.Japan
    • 10.4.9.1.Overview
    • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3.Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.4.9.4.Japan Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.4.9.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.10.South Korea
    • 10.4.10.1.Overview
    • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3.South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.4.10.4.South Korea Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.4.10.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.11.Australia
    • 10.4.11.1.Overview
    • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3.Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.4.11.4.Australia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.4.11.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.12.Thailand
    • 10.4.12.1.Overview
    • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3.Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.4.12.4.Thailand Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.4.12.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.13.Indonesia
    • 10.4.13.1.Overview
    • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3.Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.4.13.4.Indonesia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.4.13.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.14.Philippines
    • 10.4.14.1.Overview
    • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3.Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.4.14.4.Philippines Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.4.14.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.15.Rest of APAC
    • 10.4.15.1.Overview
    • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3.Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.4.15.4.Rest of APAC Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.4.15.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 10.5.Latin America
  • 10.5.1.Overview
  • 10.5.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Latin America
  • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4.Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  • 10.5.5.Latin America Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  • 10.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.7.Brazil
    • 10.5.7.1.Overview
    • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3.Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.5.7.4.Brazil Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.5.7.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.8.Mexico
    • 10.5.8.1.Overview
    • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3.Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.5.8.4.Mexico Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.5.8.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.9.Argentina
    • 10.5.9.1.Overview
    • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3.Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.5.9.4.Argentina Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.5.9.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.10.Colombia
    • 10.5.10.1.Overview
    • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3.Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.5.10.4.Colombia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.5.10.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.11.Rest of LATAM
    • 10.5.11.1.Overview
    • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 10.6.Middle East and Africa
  • 10.6.1.Overview
  • 10.6.2.Live Biotherapeutics Products & Microbe CDMO Key Manufacturers in Middle East and Africa
  • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4.Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  • 10.6.5.Middle East and Africa Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
  • 10.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.7.Saudi Arabia
    • 10.6.7.1.Overview
    • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.8.United Arab Emirates
    • 10.6.8.1.Overview
    • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.9.Israel
    • 10.6.9.1.Overview
    • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3.Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.6.9.4.Israel Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.6.9.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.10.Turkey
    • 10.6.10.1.Overview
    • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3.Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.6.10.4.Turkey Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.6.10.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.11.Algeria
    • 10.6.11.1.Overview
    • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3.Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.6.11.4.Algeria Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.6.11.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.12.Egypt
    • 10.6.12.1.Overview
    • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3.Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.6.12.4.Egypt Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.6.12.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.13.Rest of MEA
    • 10.6.13.1.Overview
    • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3.Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 10.6.13.4.Rest of MEA Market Size and Forecast, By Scale of Operation, 2019 - 2032 (US$ Million)
    • 10.6.13.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Live Biotherapeutics Products & Microbe CDMO Industry

• 11.1.Competitive Dashboard
• 11.2.Company Profiles
  • 11.2.1.4D Pharma PLC
  • 11.2.2.Catalent, Inc.
  • 11.2.3.Chr. Hansen Holding A/S
  • 11.2.4.Evelo Biosciences, Inc.
  • 11.2.5.Evonik Industries AG
  • 11.2.6.Ferring Pharmaceuticals
  • 11.2.7.Lonza Group AG
  • 11.2.8.Microbiotica Ltd.
  • 11.2.9.Pivot Bio
  • 11.2.10.Rebiotix, Inc. (a Ferring Pharmaceuticals company)
  • 11.2.11.Samsung Biologics
  • 11.2.12.Second Genome, Inc.
  • 11.2.13.Seres Therapeutics, Inc.
  • 11.2.14.Synlogic, Inc.
  • 11.2.15.Vedanta Biosciences, Inc.
  • 11.2.16.Wacker Chemie AG
  • 11.2.17.Others

12.360 Degree Analyst View

13.Appendix

• 13.1.Research Methodology
• 13.2.References
• 13.3.Abbreviations
• 13.4.Disclaimer
• 13.5.Contact Us